Ultrasound changes in fibroids during Relugolix treatment
Part of Cancer, Skin, Women’s health & pregnancy clinical trials.
This study tests whether an ultrasound can show how fibroids (benign uterine growths) change during treatment with a medication called Relugolix (combined with estrogen and progestin). It's for women who have heavy bleeding and want to know if the medication can shrink their fibroids.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are still having periods (premenopausal)
- You have fibroids (benign muscle growths in the uterus) that are larger than 10mm
- You have symptoms like heavy or irregular bleeding
- You have digital ultrasound images of your fibroids
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if relugolix can reduce heavy menstrual bleeding caused by uterine fibroids. It may be an option for women who want to avoid surgery.
This study tests how well a long-term treatment using a relugolix combination tablet helps protect bone density in women who have uterine fibroids or endometriosis. It may help people who are at risk of bone thinning while receiving hormone-related symptom treatment.
This trial tests if the drug letrozole can improve symptoms like heavy bleeding and pelvic pain caused by uterine fibroids. You must be premenopausal with moderate to severe symptoms and not have very large fibroids or certain other conditions.
This trial is testing a medicine called Relugolix to see if it helps reduce pain related to endometriosis. If you have confirmed endometriosis and are already taking Relugolix for at least a month with significant pain, this study might be for you.
This trial compares two treatments for painful or heavy menstrual bleeding caused by uterine fibroids: high-intensity focused ultrasound (HIFU) and myomectomy (surgery to remove fibroids). It may help you decide which option fits your needs.
This trial tests whether taking a medication (Rel-CT) after surgery helps improve outcomes for people with endometriosis. It may reduce the chance of symptoms returning after the tissue is removed.
Hear when a new Uterine Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.